The Cell Culture Core is to serve several main functions. It will be a cost-effective, time-saving resource for a) freshly cultured and immortalized skin cells and skin equivalents; b) genetically modified skin cells; c) specialized media; d) antibodies and molecular probes for detection of skin specific markers. In addition, it will be a center for: a) information and advice in cell culture techniques; and b) development of new techniques applicable to skin research, such as optimizing procedures for efficient gene delivery into fastidious cells (endothelial cells and melanocytes) and tissue engineering that can be used for wound healing. The latter function will be performed in collaboration with the SCID mouse/Human Xenograft Core and the Tissue Aquisition & Analysis Core of the YSDRCC. The core will provide: 1. Primary cultures of normal human skin ceils (melanocytes, keratinocytes, fibroblasts and endothelial cells) from healthy donors, as well as malignant, mutant and other abnormal cells from the same patient or different patients; 2. Primary and immortalized mouse cells; 3. Genetically modified mouse melanocytes keratinocytes and fibroblasts; 4. Co-cultures, e.g., keratinocytes/melanocytes, fibroblasts/melanocytes, fibroblasts/keratinocytes; endothelial cells/keratinocytes; and various combinations thereof; 5. Skin equivalents; 6. Large volumes of cells for specified procedures such as the construction of cDNA libraries, analysis of genetic alterations, global gene expression by microarrays (mRNA), protein purification, proteomics, identification of cell surface proteins; 7. Advice and hands-on training for the growing of cells especially those that have so far proven fastidious, such as CTCL and melanocytes from primary melanomas from the radial growth phase. Significance: 1. The core provides cells to individual investigators who lack the expertise or equipment, and to others who wish to save the labor-intensive process. Both groups enjoy the highly economical and cost effectiveness of our services; 2. This core improves the consistency, ease and reproducibility of obtaining skin cells and skin equivalents, and thus enhances the quality of research and reduces the probability of artifacts due to the presence of mycoplasma and/or contaminating cells; 3. The expertise in the central facility provides advice and hands-on help to scientists in growing normal cells that otherwise have been known to be recalcitrant; 4. The core brings together scientists with common interests and enhances interactions that otherwise would not materialize; 5. The core will enhance the formation of new core facilities, such as imaging; 6. The core provides primary cultures and special cell types to investigators outside of Yale.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
New Haven
United States
Zip Code
Dainichi, Teruki; Hayden, Matthew S; Park, Sung-Gyoo et al. (2016) PDK1 Is a Regulator of Epidermal Differentiation that Activates and Organizes Asymmetric Cell Division. Cell Rep 15:1615-23
Askenase, Phillip W; Bryniarski, Krzysztof; Paliwal, Vipin et al. (2015) A subset of AID-dependent B-1a cells initiates hypersensitivity and pneumococcal pneumonia resistance. Ann N Y Acad Sci 1362:200-14
Clark, Paul R; Jensen, Todd J; Kluger, Martin S et al. (2011) MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells. Microcirculation 18:102-17
Kwong, Bernice Y; Roberts, Scott J; Silberzahn, Tobias et al. (2010) Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis. J Invest Dermatol 130:1726-36
Radtke, Christine; Vogt, Peter M; Devor, Marshall et al. (2010) Keratinocytes acting on injured afferents induce extreme neuronal hyperexcitability and chronic pain. Pain 148:94-102
Kirkiles-Smith, Nancy C; Harding, Martha J; Shepherd, Benjamin R et al. (2009) Development of a humanized mouse model to study the role of macrophages in allograft injury. Transplantation 87:189-97
Koga, Yasuo; Pelizzola, Mattia; Cheng, Elaine et al. (2009) Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res 19:1462-70
Yates, Kristin E; Korbel, Gregory A; Shtutman, Michael et al. (2008) Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell 7:609-21
Pelizzola, Mattia; Koga, Yasuo; Urban, Alexander Eckehart et al. (2008) MEDME: an experimental and analytical methodology for the estimation of DNA methylation levels based on microarray derived MeDIP-enrichment. Genome Res 18:1652-9
Shen, Xiaoyan; Berger, Carole L; Tigelaar, Robert et al. (2008) Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loading. Immunol Invest 37:798-821

Showing the most recent 10 out of 97 publications